2022 - Research.com Best Female Scientist Award
Her primary scientific interests are in Immunology, Dendritic cell, Immune system, Antigen-presenting cell and Antigen presentation. Her work carried out in the field of Immunology brings together such families of science as Cytotoxic T cell and Cell biology. Her work is dedicated to discovering how Cytotoxic T cell, T cell are connected with Vaccinia and other disciplines.
Her research in Dendritic cell intersects with topics in Chemokine, Phenotype, CD11c and Cytokine. Her biological study spans a wide range of topics, including Cancer research and Virulence. Her Antigen presentation study integrates concerns from other disciplines, such as Cellular differentiation, Cellular immunity, Follicular dendritic cells and Tuberculosis, Mycobacterium tuberculosis.
Immunology, Immune system, Antigen, Dendritic cell and T cell are her primary areas of study. She combines subjects such as Cytotoxic T cell and Cell biology with her study of Immunology. She interconnects Cancer research and Melanoma in the investigation of issues within Immune system.
The concepts of her Antigen study are interwoven with issues in Virology and Vaccination. The various areas that Nina Bhardwaj examines in her Dendritic cell study include Priming, Cytokine and Immunity. Her Antigen-presenting cell research includes themes of Natural killer T cell, Interleukin 12 and Major histocompatibility complex.
Her primary areas of study are Cancer research, Immune system, Immunotherapy, Cancer and Antigen. The Cancer research study combines topics in areas such as Bladder cancer, Cytotoxic T cell, Dendritic cell and Immune checkpoint. Her Dendritic cell research is multidisciplinary, relying on both Antitumor immunity and Cell biology.
Nina Bhardwaj has included themes like Proinflammatory cytokine and Cytokine in her Immune system study. Antigen is a subfield of Immunology that Nina Bhardwaj tackles. Her study looks at the relationship between T cell and fields such as CD8, as well as how they intersect with chemical problems.
Her main research concerns Cancer research, Immunotherapy, Antigen, Immune system and T cell. Her Cancer research research incorporates elements of Bladder cancer, Cancer, CD8, Immunity and Cytotoxic T cell. Her work in the fields of Antigen presentation overlaps with other areas such as GZMB.
Nina Bhardwaj focuses mostly in the field of Immunotherapy, narrowing it down to topics relating to Dendritic cell and, in certain cases, Cell biology, C-C chemokine receptor type 7, Downregulation and upregulation and CD40. Her Immune system study is focused on Immunology in general. The study incorporates disciplines such as Tumor microenvironment, Priming, Cytokine and Immune checkpoint in addition to T cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Matthew L. Albert;Birthe Sauter;Nina Bhardwaj.
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.
Madhav V. Dhodapkar;Ralph M. Steinman;Joseph Krasovsky;Christian Munz.
Journal of Experimental Medicine (2001)
Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.
Birthe Sauter;Matthew L. Albert;Loise Francisco;Marie H. Larsson.
Journal of Experimental Medicine (2000)
Immunology of COVID-19: Current State of the Science.
Nicolas Vabret;Graham J. Britton;Conor Gruber;Samarth Hegde.
Immune and Clinical Responses in Patients with Metastatic Melanoma to CD34+ Progenitor-derived Dendritic Cell Vaccine
Jacques Banchereau;A. Karolina Palucka;Madhav Dhodapkar;Susan Burkeholder.
Cancer Research (2001)
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
Armin Bender;Mark Sapp;Gerold Schuler;Ralph M. Steinman.
Journal of Immunological Methods (1996)
Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature.
U O'Doherty;M Peng;S Gezelter;W J Swiggard.
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor–viral RNA interactions
Anne-Sophie Beignon;Kelli McKenna;Mojca Skoberne;Olivier Manches.
Journal of Clinical Investigation (2005)
Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells
Kayo Inaba;Shannon Turley;Fumiya Yamaide;Tomonori Iyoda.
Journal of Experimental Medicine (1998)
Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Hélène Salmon;Juliana Idoyaga;Adeeb Rahman;Marylène Leboeuf.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: